336 related articles for article (PubMed ID: 7851356)
1. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
Van den Broek L; Proost JH; Wierda JM; Njoo MD; Hennis PJ
Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
3. Time course of action and recovery of rocuronium bromide in children during halothane anaesthesia--a preliminary report.
Motsch J; Leuwer M; Pfau M; Zimmerman J; Martin E
Eur J Anaesthesiol Suppl; 1994; 9():75-7. PubMed ID: 7925213
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
5. Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles.
Suzuki T; Mizutani H; Miyake E; Fukano N; Saeki S; Ogawa S
Acta Anaesthesiol Scand; 2009 Nov; 53(10):1336-40. PubMed ID: 19650798
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
7. Early and late reversibility of rocuronium bromide.
van den Broek L; Proost JH; Wierda JM
Eur J Anaesthesiol Suppl; 1994; 9():128-32. PubMed ID: 7925203
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
Davis L; Jayarajah MJ; Toner CC; Flynn PJ
Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
11. Dose-response, time-course of action and recovery of rocuronium bromide in children during halothane anaesthesia.
Motsch J; Leuwer M; Böttiger BW; Bach A; Schönstedt R; Martin E
Eur J Anaesthesiol Suppl; 1995 Sep; 11():73-8. PubMed ID: 8557011
[TBL] [Abstract][Full Text] [Related]
12. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neuromuscular block of atracurium and rocuronium in adults.
Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
[TBL] [Abstract][Full Text] [Related]
14. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
15. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
17. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of atracurium-induced block in obese patients.
Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
[TBL] [Abstract][Full Text] [Related]
19. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
20. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
